Follow

Clarify Pharma Plc

AQSE Growth Market (United Kingdom)

Clarify seeks to develop a business concentrating on high potential and fast-growing biotech and life science companies that perform research or produce neuro-pharmaceutical drug development platforms. The focus will be on businessesthat advance medicines based on psychedelic substances through rigorous science and clinical trials.

Sector:
HEALTH CARE
>
Pharmaceuticals And Biotechnology
News
No available news yet for Clarify Pharma Plc
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
PSYC
GB00BMCD8M81
AQSE Growth Market
United Kingdom (GB)
Details of share in Clarify Pharma Plc with ticker PSYC
Status
Active
SEDOL
BMCD8M8
Amount of instruments
297 195 000
Par value
Currency
GBP
Segment
AQSE Growth Market
Type
Price
Pre-money
Time
Files
Listing
0.025 GBP
74.3M GBP
11 Jun 2021
Direct listing of Clarify Pharma Plc on AQSE Growth Market
People
Jonathan Bixby
Chairman of the board
Nicholas James Lyth
Board member
Michael Edwards
Board member
Jonathan Hives
Board member
John Patrick Mcbride
Board member
Company Details
Sector
HEALTH CARE

Address
Great Queen Street
Zip code
WC2B 5DG
City/district
London
Country
United Kingdom (GB)
Email
Registration number
12294271
LEI code
984500B744CA787B4C14
First trade date
11 Jun 2021
Company former names
MENA ESPORTS PLC
04 Feb 2021
Registration date
01 Nov 2019
Short name
Clarify Pharma

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More